Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 1, 2000, Pages 193-199

  Colao, Annamaria ^a   Baldelli, Roberto ^b   Marzullo, Paolo ^a   Ferretti, Elisabetta ^b   Ferone, Diego ^a   Gargiulo, Patrizia ^b   Petretta, Mario ^a   Tamburrano, Guido ^b   Lombardi, Gaetano ^a   Liuzzi, Antonio ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CARDIOMYOPATHY; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HEART VENTRICLE SEPTUM; HORMONE BLOOD LEVEL; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ACROMEGALY; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; CARDIOMYOPATHIES; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN GROWTH HORMONE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM;

EID: 17744362863     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.1.193     Document Type: Article

References (37)

1. Acromegaly
2. Mortality in acromegaly
3. Epidemiology and long term survival in acromegaly
4. Mortality and cancer incidence in acromegaly: A retrospective cohort study
5. Growth-hormone and prolactin excess
6. Heart muscle disease in acromegaly
7. Echocardiographic assessment of cardiac anatomy and function in acromegalic patient
8. Cardiac hypertrophy and function in asymptomatic acromegaly
9. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study
10. Impaired left ventricular diastolic function in acromegaly: An echocardiographic study
11. Subclinical cardiac dysfunction in acromegaly: Evidence for a specific disease of heart muscle
12. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension
13. Cell death in acromegalic cardiomyopathy
14. Impact of patient's age and disease duration on cardiac performance in acromegaly: A radionuclide angiography study
15. Acromegaly
16. Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics
17. Type 2 diabetes: One disease, multiple cardiovascular risk factors
18. Prevention of first stroke: A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association
19. Hypertension control. Report of a WHO expert committee
20. Glucose tolerance and mortality: Comparison of WHO and American Diabetes Association diagnostic criteria
21. The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: Results of a survey of echocardiography measurements
22. A new simplified and accurate method for determining ejection fraction with two-dimensional echocardiography
23. Inhibitory effect of octreotide on growth hormone-induced IGF-I generation and organ growth in hypophysectomized rats
24. Growth hormone regulates the level of insulin-like growth factor-I mRNA in rats skeletal muscle
25. Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes
26. Induction of cardiac insulin-like growth factor-I gene expression in pressure overload hypertrophy
27. Left ventricular insulin-like growth factor-I increases in early renal hypertension
28. Upregulation of IGF-I, IGF-I receptor and late growth-related genes in ventricular myocytes after infarction in rats
29. Effects of chronic growth hormone hypersecretion on intrinsic contractility, energetics, isomyosin pattern, and myosin adenosine triphosphatase activity of rat left ventricle
30. 2+ handling and enhance cardiac performance. In vitro evaluation in the isolated isovolumic buffer-perfused rat heart
31. Growth hormone and the heart
32. Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly
33. Cardiac effects of lanreotide, a slow release somatostatin analog, in acromegalic patients
34. Regression of acromegalic left ventricular hypertrophy after lanreotide (a slow-release somatostatin analog)
35. Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects
36. Anatomie pathologique, lesions et trouble cardiovasculaires de l'acromegalie